124I-AT03 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
28全身性アミロイドーシス1

28. 全身性アミロイドーシス


臨床試験数 : 261 薬物数 : 276 - (DrugBank : 81) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 178
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05201911
(ClinicalTrials.gov)
November 30, 20212/12/2021A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic AmyloidosisA Single Arm, Single Dose Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Select Organs in Patients With Systemic AmyloidosisAmyloidosis; SystemicDrug: 124I-AT03Attralus, Inc.NULLRecruiting18 YearsN/AAll20Phase 1United States